skip to content

Department of Oncology

 
Read more at: Revised clinical guidelines for treating cancer patients during COVID-19 pandemic

Revised clinical guidelines for treating cancer patients during COVID-19 pandemic

20 April 2020

Professor Richard Gilbertson (Head of Department of Oncology and Director of CRUK Cambridge Centre) would like to bring to your attention an important paper recently published in Nature Medicine, co-authored by Carlos Caldas (Department of Oncology), . Cambridge and six other leading cancer centres across Europe have...


Read more at: Predicting cancer risk through studying mutations in blood

Predicting cancer risk through studying mutations in blood

20 April 2020

Cancer is evolution at the cellular level. As we age, we acquire mutations in the cells that make up our tissues. Whilst the vast majority of these mutations are harmless, some of them can increase the risk of developing cancer. In research recently published in Science Jamie Blundell's Group (Department of Oncology)...


Read more at: Cambridge in top 20 cancer centres in Europe

Cambridge in top 20 cancer centres in Europe

20 April 2020

Many congratulations to the Cancer Research UK Cambridge Centre, led by Professor Richard Gilbertson, which has been re-accredited as a Comprehensive Cancer Centre by the Organisation of European Cancer Institutes (OECI) for a further five years. This is a prestigious designation which is only given to the top 20 Cancer...


Read more at: Mapping breast cancer cell by cell

Mapping breast cancer cell by cell

20 February 2020

Scientists have created one of the most detailed maps of breast cancer ever achieved, revealing how genetic changes shape the physical tumour landscape, according to research funded by Cancer Research UK and published in Nature Cancer . Professor Carlos Caldas, along with an international team of scientists from Cambridge...


Read more at: Genetic study provides the most comprehensive map to date of breast cancer risk

Genetic study provides the most comprehensive map to date of breast cancer risk

20 February 2020

A major international study of the genetics of breast cancer has identified more than 350 DNA ‘errors’ that increase an individual’s risk of developing the disease. The team led by Alison Dunning states that these errors may influence as many as 190 genes. The results, published in Nature Genetics , provide the most...


Read more at: Researchers collaborate on new drug combinations for melanoma

Researchers collaborate on new drug combinations for melanoma

29 November 2019

The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a collaborative study published in Nature Communications . Professor Duncan Jodrell, Department of Oncology, and fellow Cancer...


Read more at: CRUK invests £56 million to set up a UK network of excellence in radiation research

CRUK invests £56 million to set up a UK network of excellence in radiation research

7 November 2019

On 04 November 2019, Cancer Research UK announced a £56m investment in CRUK RadNet, their largest ever investment in radiotherapy research. CRUK RadNet is a national network of 7 centres of excellence in radiation research. It unites the universities of Cambridge, Glasgow, Leeds, Manchester and Oxford, the CRUK City of...


Read more at: International Alliance for Cancer Early Detection

International Alliance for Cancer Early Detection

7 November 2019

On 21 October 2019, Cancer Research UK launched the International A lliance for C ancer E arly D etection (ACED) to help accelerate and revolutionise research in the early detection of cancers through collaboration between the UK and the US. ACED is a partnership between Cancer Research UK, Canary Center at Stanford...


Read more at: Highly sensitive blood test detects early stage breast cancer

Highly sensitive blood test detects early stage breast cancer

7 November 2019

Researchers from the CRUK Cambridge Centre, including Carlos Caldas (Department of Oncology), Stephen-John Sammut and Suet-Feung Chin (both CRUK Cambridge Institute), working with scientists from the Translational Genomics Research Institute in the US, have developed a personalised blood test to detect fragments of...


Read more at: Jamie Blundell named as UKRI Future Leaders Fellow

Jamie Blundell named as UKRI Future Leaders Fellow

7 November 2019

Congratulations to Jamie Blundell (Oncology, CRUK Cambridge Centre Early Detection Programme) who has been awarded a £1.2 million Future Leaders Fellowship by UK Research and Innovation (UKRI). The fellowship will enable Jamie to build a team in the CRUK Cambridge Centre Early Detection Programme , with the aim of...